CN219376888U

CN219376888U - Oscillator for pharmaceutical drug experiments

Info

Publication number: CN219376888U
Application number: CN202223315948.5U
Authority: CN
Inventors: 樊斯婷; 刘丽敏
Original assignee: Individual
Current assignee: Individual
Priority date: 2022-12-10
Filing date: 2022-12-10
Publication date: 2023-07-21
Anticipated expiration: 2032-12-10

Abstract

The utility model relates to the technical field of pharmaceutical experimental apparatuses, in particular to an oscillator for pharmaceutical experiments, which comprises a first mounting groove, a second mounting groove, test tube racks, beaker holders and a driving mechanism, wherein the first mounting groove and the second mounting groove are arranged side by side, a plurality of test tube racks are vertically and rotationally arranged in the first mounting groove, and the beaker holders are vertically and rotationally arranged in the second mounting groove; the driving mechanism is used for driving the test tube rack and the beaker rack to horizontally rotate. Test tube rack and beaker frame set up respectively in first mounting groove and the second mounting groove, can install test tube and beaker respectively to be provided with can drive test tube rack and beaker frame horizontal pivoted actuating mechanism, thereby can carry out the vibration to the medicine of different dosages and dissolve, test tube rack and beaker frame horizontal rotation adopt vertical pivoted mode for among the prior art, can reduce the incidence of liquid medicine emergence bubble drip phenomenon.

Description

Oscillator for pharmaceutical drug experiments

Technical Field

The utility model relates to the technical field of pharmaceutical experimental apparatuses, in particular to an oscillator for pharmaceutical drug experiments.

Background

The traditional medicine dissolving method is to mix two or more medicines and then shake the medicines manually so as to achieve the purpose of fully mixing, and the operation has the following defects: the mixing is uneven, so that the experimental effect is inaccurate, the manual mixing efficiency is low, and the single mixing amount is limited. The prior oscillator for dissolving the prior medical medicine is suitable for dissolving powder in dissolving liquid to carry out small amount of dissolution and mixing, is not suitable for large-dose insoluble mixing for experiments, and is inconvenient for dissolution and mixing of dissolution containers with different sizes.

Based on this, CN217016374U discloses an oscillator for pharmaceutical drug experiments, which has a simple structure, and can be used to arbitrarily customize the number of holes and the size of the hole according to the needs, so as to adapt to different containers. But its is not enough, and it passes through the output shaft of motor and is connected with the transmission shaft through the shaft coupling to drive the support frame and rotate, thereby drive the reagent case and rotate, the reagent pipe is placed in the reagent case, takes place 360 rotations, and although it is provided with spring and rubber piece in reagent pipe top, to some reagent pipes that do not have the lid, it can cause the problem of running off and leaking because of the vibration amplitude is big.

Disclosure of Invention

The utility model aims to solve the problems that the vibration amplitude is large and the liquid in a reagent tube is easy to leak and leak in the existing oscillator for pharmaceutical drug experiments.

The utility model provides an oscillator for pharmacy medicine experiments, includes first mounting groove, second mounting groove, test-tube rack, beaker frame and actuating mechanism, first mounting groove sets up side by side with the second mounting groove, a plurality of the test-tube rack is vertical and rotate set up in the first mounting groove, the beaker frame is vertical and rotate set up in the second mounting groove; the driving mechanism is used for driving the test tube rack and the beaker rack to horizontally rotate.

Further, the driving mechanism comprises a motor, a first rotating shaft and a second rotating shaft are respectively and vertically fixedly connected with the bottom of the test tube rack and the bottom of the beaker rack, and the motor is in transmission connection with the first rotating shaft and the second rotating shaft.

Further, the test tube rack and the beaker rack are distributed in rows, the motor is arranged beside the first mounting groove and the second mounting groove, the first rotating shaft and the second rotating shaft which are closest to the motor in each row are in belt transmission with the motor, and the gear transmission is realized between the first rotating shaft and the second rotating shaft in each row.

Further, a driving cavity is arranged below and beside the first mounting groove and the second mounting groove, the motor is mounted in the driving cavity, and the first rotating shaft and the second rotating shaft extend into the driving cavity and are rotationally connected with the lower end face of the driving cavity.

Further, a closed cavity is arranged below the first mounting groove and the second mounting groove, a plurality of ultrasonic transducers are arranged in the closed cavity, and the ultrasonic transducers are connected with an ultrasonic generator through wires.

Further, a shell is arranged outside the closed cavity, the ultrasonic generator is installed in the shell, a first switch for controlling the motor is arranged outside the shell, and the first switch is a multi-stage speed regulating switch.

Further, a second switch for controlling the ultrasonic generator is arranged on the outer side of the shell, and the second switch is a frequency modulation switch.

Further, a display and a main switch for displaying the motor rotation speed and the ultrasonic generator frequency are arranged on the outer side of the shell.

Compared with the prior art, the utility model has the beneficial effects that:

according to the oscillator for pharmaceutical drug experiments, the test tube rack and the beaker rack are respectively arranged in the first mounting groove and the second mounting groove, so that test tubes and beakers can be respectively mounted, and the driving mechanism capable of driving the test tube rack and the beaker rack to horizontally rotate is arranged, so that drugs with different dosages can be oscillated and dissolved. The test tube rack and the beaker rack horizontally rotate in a vertical rotating mode relative to the prior art, and the horizontal rotating speed can be adjusted by arranging the multi-stage speed regulating switch, so that the phenomenon that liquid medicine in the test tube and the beaker leaks in a running mode is effectively avoided.

The oscillator for pharmaceutical drug experiments is provided with the ultrasonic generator and the ultrasonic transducer on the basis of motor driving, and has the function of ultrasonic oscillation on the basis of rotation oscillation, thereby being beneficial to accelerating the oscillation reaction, and being capable of carrying out ultrasonic cleaning on the test tube rack and the beaker rack after oscillation.

Drawings

The accompanying drawings are included to provide a further understanding of the utility model and are incorporated in and constitute a part of this specification, illustrate the utility model and together with the embodiments of the utility model, serve to explain the utility model. In the drawings:

fig. 1 is a schematic diagram showing the overall structure of an oscillator for pharmaceutical drug experiments in an embodiment of the present utility model.

Fig. 2 is a top view of a pharmaceutical drug test shaker in an embodiment of the present utility model.

FIG. 3 is a cross-sectional view A-A of FIG. 2.

Fig. 4 is a schematic diagram showing a partial structure of an experimental oscillator for pharmaceutical drugs in an embodiment of the present utility model.

In the figure: 1. a first mounting groove; 2. a test tube rack; 3. a second mounting groove; 4. a cup holder; 5. a motor; 6. a first rotation shaft; 7. a second rotation shaft; 8. a drive chamber; 9. a closed cavity; 10. an ultrasonic transducer; 11. an ultrasonic generator; 12. a housing; 13. a first switch; 14. a second switch; 15. a display; 16. a main switch; 17. a first rotating disc; 18. a second rotating disc; 19. a first belt; 20. a second belt; 21. a third belt; 22. a fourth belt; 23. a fifth belt; 24. a first gear; 25. and a second gear.

Detailed Description

The following description of the embodiments of the present utility model will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present utility model, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the utility model without making any inventive effort, are intended to be within the scope of the utility model.

Specific examples:

the combination is as shown in fig. 1 and 4, and the oscillator for pharmaceutical drug experiments in this embodiment comprises a first mounting groove 1, a second mounting groove 3, test tube racks 2, a cup rack 4 and a driving mechanism, wherein the first mounting groove 1 and the second mounting groove 3 are open at the upper end and are integrally arranged side by side, a plurality of test tube racks 2 are arranged in a row and vertically rotate in the first mounting groove 1, and the beaker racks 4 are also arranged in a row and vertically rotate in the second mounting groove 3. Specifically, two rows of test tube racks 2 are arranged in the first mounting groove 1 in the embodiment, and two beaker frames 4 are arranged side by side in the second mounting groove 3. The bottom of the test tube rack 2 and the beaker rack 4 are respectively and horizontally provided with a first rotating disc 17 and a second rotating disc 18, and the first rotating disc 17 and the second rotating disc 18 are respectively and fixedly connected with the test tube rack 2 and the beaker rack 4. A first rotating shaft 6 and a second rotating shaft 7 are vertically arranged below the first rotating disc 17 and the second rotating disc 18 respectively, and the first rotating shaft 6 and the second rotating shaft 7 are fixedly connected with the first rotating disc 17 and the second rotating disc 18 respectively. The first rotating shaft 6 and the second rotating shaft 7 are respectively and rotatably connected with the lower end surfaces of the first mounting groove 1 and the second mounting groove 3.

As shown in fig. 3, a driving cavity 8 is provided below and beside the first mounting groove 1 and the second mounting groove 3. The driving mechanism comprises a motor 5 and a transmission shaft, and the motor 5 is arranged in the driving cavity 8 and is positioned beside the first mounting groove 1 and the second mounting groove 3. The transmission shaft is vertically arranged below the motor 5 and fixedly connected with an output shaft of the motor 5, and the transmission shaft is arranged on a connecting line of one row of test tube racks 2, which is close to the beaker holder 4, in the two rows of test tube racks 2. The transmission shaft is sequentially and fixedly provided with a first driving wheel, a second driving wheel and a third driving wheel. The first driven wheel is arranged on the first rotating shaft 6 which is positioned in the row of the first rotating shafts 6 on the same line with the transmission shaft and is closest to the transmission shaft, and the first driven wheel is at the same height as the first driving wheel, and the first driving wheel is in transmission connection with the first driven wheel through a first belt 19.

The driving cavity 8 is rotatably provided with a first driving shaft and a second driving shaft, and the first driving shaft and the second driving shaft are respectively positioned at two sides of the transmission shaft. The first driving shaft is provided with a second driven wheel, the second driven wheel is co-altitude with a second driving wheel, and the second driving wheel is in transmission connection with the second driven wheel through a second belt 20. The first driving shaft is also provided with a fourth driving wheel, a row of first rotating shafts 6 far away from the beaker holder 4 and a fourth driven wheel is arranged on the first rotating shaft 6 closest to the transmission shaft, and the fourth driving wheel is in transmission connection with the fourth driven wheel through a fourth belt 22.

The second driving shaft is provided with a third driven wheel, the third driven wheel is co-high with a third driving wheel, and the third driving wheel is in transmission connection with the third driven wheel through a third belt 21. The second driving shaft is also provided with a fifth driving wheel, a row of second rotating shafts 7 far away from the beaker holder 4, and a fifth driven wheel is arranged on the second rotating shaft 7 closest to the transmission shaft, and the fifth driving wheel is in transmission connection with the fifth driven wheel through a fifth belt 23.

The first rotation shaft 6 and the second rotation shaft 7 are respectively provided with a first gear 24 and a second gear 25, the first gears 24 positioned in the same row are meshed with each other, and the second gears 25 are meshed with each other. In this embodiment, the first gear 24, the second gear 25, the driving wheel and the driven wheel are all disposed in the driving chamber 8. The first rotating shaft 6, the second rotating shaft 7, the transmission shaft, the first driving shaft and the second driving shaft are all in rotary connection with the lower end face of the driving cavity 8.

In this embodiment, as shown in fig. 3, a housing 12 is disposed below the first mounting groove 1 and the second mounting groove 3, a closed cavity 9 is disposed in the housing 12, a plurality of ultrasonic transducers 10 are disposed in the closed cavity 9, and the plurality of ultrasonic transducers 10 are connected to an ultrasonic generator 11 through wires. The ultrasonic generator 11 is disposed outside the closed chamber 9 and inside the housing 12.

In this embodiment, as shown in fig. 2, a first switch 13 for controlling the motor 5 and a second switch 14 for controlling the ultrasonic generator 11 are disposed outside the housing 12, the first switch 13 is a multi-stage speed regulation switch, and the second switch 14 is a frequency modulation switch. Through setting up first switch 13 and second switch 14, can adjust the rotational speed of motor 5 and the frequency of supersonic generator 11 to adjust the oscillation amplitude, thereby guarantee the vibration effect as far as possible, under the prerequisite of accelerating the dissolution fusion speed, avoid the liquid medicine in test tube and the beaker to take place bubble and emit the phenomenon of drip.

In this embodiment, a display 15 and a main switch 16 are disposed on the outer side of the housing 12, the display 15 is used for displaying the rotation speed of the motor 5 and the frequency of the ultrasonic generator 11, and the main switch 16 is used for controlling the overall opening and closing of the device.

In this embodiment, the motor 5 is a stepper motor 5, so that the motor 5 can drive the test tube and the beaker to rotate positively and negatively, and the oscillation effect is enhanced.

In other embodiments, heating rods are further disposed in the first mounting groove 1 and the second mounting groove 3, and a temperature regulating switch for controlling the heating rods is disposed outside the housing 12. When the device is used, water is added into the first mounting groove 1 and the second mounting groove 3, the heating rod is started to heat the water in the first mounting groove 1 and the second mounting groove 3, so that the liquid medicine in the test tube and the beaker can be subjected to constant-temperature oscillation, the dissolving speed of the reagent is further accelerated, and the dissolving time is reduced.

The working principle of the oscillator for pharmaceutical drug experiments in this embodiment is:

when the test tube and the beaker are used, the test tube and the beaker are respectively placed in the test tube rack 2 and the beaker rack 4, the motor 5 is started, the output shaft of the motor 5 drives the transmission shaft to rotate, the first driving wheel, the second driving wheel and the third driving wheel are driven to rotate due to the fact that the first driving wheel, the second driving wheel and the third driving wheel are fixedly connected with the transmission shaft, the first driving wheel, the second driving wheel and the third driving wheel are respectively driven by the first driven wheel, the second driven wheel and the third driven wheel, the fourth driving wheel and the fifth driving wheel are driven by the fourth driving wheel and the fifth driven wheel, the first rotating shaft 6 and the second rotating shaft 7 which are closest to the motor 5 in each row are driven to rotate due to the fact that the first rotating shaft 6 and the second rotating shaft 7 which are positioned in the same row are driven by gears, the first rotating shaft 6 and the second rotating shaft 7 are driven to rotate, the test tube rack 2 and the beaker rack 4 are driven to rotate, and liquid medicine in the test tube rack and the beaker is oscillated. The ultrasonic generator 11 is started to carry out ultrasonic oscillation on the liquid medicine in the test tube and the beaker, so that the oscillation effect is enhanced.

The oscillator for pharmaceutical drug experiments in this embodiment is through adopting horizontal rotation vibration and ultrasonic oscillation's mode to vibrate the liquid medicine in test tube and the beaker, not only can carry out the vibration to the medicine of different doses and dissolve, and the mode of horizontal rotation is for adopting vertical rotation's mode in the prior art, can reduce the liquid medicine and take place the emergence rate of bubble and emit the drip phenomenon. And through setting up first switch 13 and second switch 14, can adjust the rotational speed of motor 5 and the frequency of supersonic generator 11 to adjust the oscillation amplitude, thereby guaranteeing the vibration effect as far as possible, under the prerequisite of accelerating the dissolution fusion speed, avoid the liquid medicine in test tube and the beaker to take place bubble and leak the phenomenon.

Finally, it should be noted that: the foregoing description is only a preferred embodiment of the present utility model, and the present utility model is not limited thereto, but it is to be understood that modifications and equivalents of some of the technical features described in the foregoing embodiments may be made by those skilled in the art, although the present utility model has been described in detail with reference to the foregoing embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present utility model should be included in the protection scope of the present utility model.

Claims

1. An oscillator for pharmaceutical drug experiments, comprising:

the test tube rack comprises a first mounting groove (1), wherein a plurality of test tube racks (2) are rotatably arranged in the first mounting groove (1);

the second mounting groove (3), the second mounting groove (3) is arranged side by side with the first mounting groove (1), and the second mounting groove (3) is rotatably provided with a cup holder (4);

the driving mechanism is used for driving the test tube rack (2) and the beaker rack (4) to horizontally rotate.

2. The oscillator for pharmaceutical drug experiments according to claim 1, wherein the driving mechanism comprises a motor (5), a first rotating shaft (6) and a second rotating shaft (7) are vertically and fixedly connected to the bottoms of the test tube rack (2) and the beaker rack (4), and the motor (5) is in transmission connection with the first rotating shaft (6) and the second rotating shaft (7).

3. The oscillator for pharmaceutical drug experiments according to claim 2, wherein the test tube rack (2) and the beaker rack (4) are distributed in rows, the motor (5) is mounted beside the first mounting groove (1) and the second mounting groove (3), the first rotating shaft (6) and the second rotating shaft (7) closest to the motor (5) in each row are in belt transmission with the motor (5), and the gears of the first rotating shaft (6) and the second rotating shaft (7) in each row are in transmission.

4. A pharmaceutical drug experimental oscillator according to claim 3, characterized in that a driving cavity (8) is arranged below and beside the first mounting groove (1) and the second mounting groove (3), the motor (5) is mounted in the driving cavity (8), and the first rotating shaft (6) and the second rotating shaft (7) extend into the driving cavity (8) and are in rotating connection with the lower end face of the driving cavity (8).

5. The oscillator for pharmaceutical drug experiments according to claim 1, wherein a closed cavity (9) is arranged below the first mounting groove (1) and the second mounting groove (3), a plurality of ultrasonic transducers (10) are arranged in the closed cavity (9), and the ultrasonic transducers (10) are connected with an ultrasonic generator (11) through wires.

6. The oscillator for pharmaceutical drug experiments according to claim 5, characterized in that a housing (12) is provided outside the closed cavity (9), the ultrasonic generator (11) is installed in the housing (12), a first switch (13) for controlling the motor (5) is provided outside the housing (12), and the first switch (13) is a multi-stage speed regulation switch.

7. The oscillator for pharmaceutical drug experiments according to claim 6, characterized in that a second switch (14) for controlling the ultrasonic generator (11) is provided outside the housing (12), the second switch (14) being a frequency modulation switch.

8. The oscillator for pharmaceutical drug experiments according to claim 7, characterized in that a display (15) and a main switch (16) for displaying the rotation speed of the motor (5) and the frequency of the ultrasonic generator (11) are provided outside the housing (12).